S2Medical AB (publ) (STO:S2M)

S2Medical AB Statistics

Total Valuation

S2Medical AB has a market cap or net worth of SEK 12.33 million. The enterprise value is 11.32 million.

Market Cap	12.33M
Enterprise Value	11.32M

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

S2Medical AB has 844.26 million shares outstanding. The number of shares has increased by 360.86% in one year.

Current Share Class	836.14M
Shares Outstanding	844.26M
Shares Change (YoY)	+360.86%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.01%
Float	836.14M

Valuation Ratios

The trailing PE ratio is 1.70.

PE Ratio	1.70
Forward PE	n/a
PS Ratio	0.84
PB Ratio	0.66
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	2.45
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.35
EV / Sales	0.77
EV / EBITDA	2.05
EV / EBIT	2.35
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87

Current Ratio	0.87
Quick Ratio	0.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	235.74

Financial Efficiency

Return on equity (ROE) is 47.23% and return on invested capital (ROIC) is 29.62%.

Return on Equity (ROE)	47.23%
Return on Assets (ROA)	12.90%
Return on Invested Capital (ROIC)	29.62%
Return on Capital Employed (ROCE)	25.79%
Revenue Per Employee	2.10M
Profits Per Employee	687,333
Employee Count	7
Asset Turnover	0.63
Inventory Turnover	0.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.94% in the last 52 weeks. The beta is 2.16, so S2Medical AB's price volatility has been higher than the market average.

Beta (5Y)	2.16
52-Week Price Change	-54.94%
50-Day Moving Average	0.02
200-Day Moving Average	0.01
Relative Strength Index (RSI)	51.19
Average Volume (20 Days)	5,282,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S2Medical AB had revenue of SEK 14.68 million and earned 4.81 million in profits. Earnings per share was 0.01.

Revenue	14.68M
Gross Profit	13.91M
Operating Income	4.83M
Pretax Income	4.81M
Net Income	4.81M
EBITDA	5.52M
EBIT	4.83M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 1.00 million in cash and n/a in debt, giving a net cash position of 1.00 million or 0.00 per share.

Cash & Cash Equivalents	1.00M
Total Debt	n/a
Net Cash	1.00M
Net Cash Per Share	0.00
Equity (Book Value)	18.72M
Book Value Per Share	0.02
Working Capital	-850,209

Cash Flow

Operating Cash Flow	5.03M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 94.79%, with operating and profit margins of 32.89% and 32.78%.

Gross Margin	94.79%
Operating Margin	32.89%
Pretax Margin	32.78%
Profit Margin	32.78%
EBITDA Margin	37.61%
EBIT Margin	32.89%
FCF Margin	n/a

Dividends & Yields

S2Medical AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-360.86%
Shareholder Yield	n/a
Earnings Yield	39.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7